Pod-Care 100Cg (betamethasone acetate and sodium phosph/norflurane/HFC 245fa)
Last reviewed · Source: First Databank (FDB) drug data
Overview
Betamethasone is a synthetic glucocorticoid.
Betamethasone and its derivatives are used principally as anti-inflammatory or immunosuppressant agents. Because betamethasone has only minimal mineralocorticoid properties, the drug is inadequate alone for the management of adrenocortical insufficiency. If betamethasone is used in the treatment of this condition, concomitant therapy with a mineralocorticoid is also required.
Generic name: betamethasone acetate and sodium phosph/norflurane/HFC 245fa
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Pod-Care 100Cg
Indications
No indications are available for this drug.
Dosing
The route of administration and dosage of betamethasone and its derivatives depend on the condition being treated and the response of the patient. Dosage for infants and children should be based on the severity of the disease and the response of the patient rather than on strict adherence to the dosage indicated by age, body weight, or body surface area. After a satisfactory response is obtained, dosage should be decreased in small decrements to the lowest level that maintains an adequate clinical response, and the drug should be discontinued gradually as soon as possible. Lack of satisfactory response after a reasonable trial of betamethasone or betamethasone sodium phosphate in fixed combination with betamethasone acetate should lead to discontinuance of therapy and transfer to other appropriate therapy. Patients should be continually monitored for signs that indicate dosage adjustment is necessary, such as remissions or exacerbations of the disease and stress (surgery, infection, trauma). Following long-term therapy, betamethasone should be withdrawn gradually. (See the Corticosteroids General Statement 68:04.)
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
There are no contraindication contraindications for this drug.
There are no severe contraindications for this drug.
There are no moderate contraindications for this drug.
Adverse reactions
There is no enhanced messaging for this drug.
There are no severe adverse reactions for this drug.
There are no less severe adverse reactions for this drug.
Precautions
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
ICD codes
No ICD codes are available for this drug.
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.